Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
miR-124a Inhibits the Proliferation and Inflammation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via Targeting PIK3/NF-b Pathway
About the analytics Our client relied on their analytic advisor team at Artemis to study the year-over-year trends from 2022 to 2023 for diabetic members taking GLP-1s compared to diabetic members not taking GLP-1s
They are GLP-1 agonists and are used to bring down blood glucose levels when other diabetes medications have stopped working or become less effective
Increased thirst is not listed amongst the common adverse effects in the Summary of Product Characteristics (SmPC) approved by the MHRA, though some patients do report experiencing thirst during treatment
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
